Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial

C. Borel , X. Sun , Alexandre Coutte (1) , G. Bera , S. Zanetta , M. Alfonsi , G. Janoray , T. Chatellier , M. Garcia-Ramirez , E. Gherga , Y. Hammoud , N. Etienne-Selloum , A. Pechery , M. H. Girard-Calais , M. Velten , J-P. Pignon , M. Wanneveich , J. Bourhis

1 CHIMERE - CHirurgie, IMagerie et REgénération tissulaire de l’extrémité céphalique - Caractérisation morphologique et fonctionnelle - UR UPJV 7516

Domaines: Sciences du Vivant [q-bio]

C. Borel, X. Sun, Alexandre Coutte, G. Bera, S. Zanetta, et al.. Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial. Annals of Oncology, 2020, 31 (4), pp.S660. ⟨10.1016/j.annonc.2020.08.1029⟩. ⟨hal-03600469⟩